XIUMEI ZHAO: Open Payments
NPI 1619554938 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 16 payments from 8 companies in 2025. Trend: 2023 $269 · 2024 $660 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 3 | $76 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Esperion Therapeutics, Inc. | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $35 |
| BridgeBio Pharma, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: NEXLETOL, OPSUMIT, Kerendia, CAMZYOS, Wegovy, INSPIRE, OPSYNVI, ELIQUIS.
Industry payments across MD — which companies pay providers there.
